Demystifying Genetic Workup of Inborn Errors of Immunity
6 affiliations
- 1Translational Immunology Research Group, Immunology Division, Vall d’Hebron Research Institute (VHIR), Hospital Universitari Vall d’Hebron (HUVH), Barcelona, Catalonia Spain
- 2Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Catalonia Spain
- 3Department of Medicine, Division of Allergy and Immunology, Montefiore Medical Center, Bronx, NY USA
- 4Division of Pediatric Genetic Medicine, Department of Pediatrics, Children’s Hospital at Montefiore, Bronx, NY USA
- 5Division of Genomics, Department of Genetics, Albert Einstein College of Medicine, Bronx, NY USA
- 6New York Center for Rare Diseases, Bronx, NY USA
Abstract
Purpose of the review: Genetically driven immune diseases (GIDs) are germline or somatic errors of immunity, representing an expanding and diagnostically complex group of genetic disorders. While genomic advances have enhanced their detection, interpretation of genetic data remains a major challenge due to significant genotypic and phenotypic heterogeneity, incomplete knowledge about genotype–phenotype connections, and the diverse layers of mechanisms contributing to each patient’s specific expression of disease. In this review, we propose a clinically oriented framework for the genetic evaluation of patients with suspected GIDs.
Recent findings: Using disorders featuring predominantly adaptive immune dysregulation as representative examples – hypomorphic defects in lymphocyte development (RAG1, RAG2), defects of central tolerance (AIRE), defects of peripheral tolerance (FOXP3), cytokine-mediated immune regulation (IL2RA, IL2RB), activation-induced cell death (FAS), and canonical NF-κB signaling (CARD11 gain-of-function) – we provide a practical approach to the selection and use of clinically available genetic tests, emphasizing context-dependent strategies based on each patient’s clinical and immune findings. We also highlight key limitations of current genetic testing and emerging approaches aimed at improving diagnostic yield.
Summary: This review provides a practical, stepwise, mechanism-informed framework for the genetic evaluation of patients with suspected GIDs that integrates clinical phenotyping with immune and genetic data. By emphasizing appropriate test selection, recognition of diagnostic limitations, and the use of complementary approaches in unresolved cases, this framework aims to support accurate molecular diagnosis and personalized management of patients with immune dysregulation.
Related
- Genetic carrier frequency in genes involved in inborn errors of immunity in the lebanese population
- Pretransplant immune dysregulation and survival after HSCT in pediatric inborn errors of immunity.
- Work participation in inborn errors of immunity: The dual burden on patients and caregivers.
- Enteropathy in inborn and acquired errors of immunity: histological patterns and clinical correlates
- Cytotoxic T-cell lymphoma with muscle involvement and germline variants in inborn error of immunity-related genes: clinical and genetic insights from a case series
BibTeX
@article{batllemaso2026demystifying,
title = {{Demystifying Genetic Workup of Inborn Errors of Immunity}},
author = {Batlle-Masó L. and Gliagias V. and Peng X.P.},
journal = {Current Allergy and Asthma Reports},
year = {2026},
month = oct,
doi = {10.1007/s11882-026-01303-3},
url = {https://doi.org/10.1007/s11882-026-01303-3},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Demystifying Genetic Workup of Inborn Errors of Immunity
AU - Batlle-Masó L.
AU - Gliagias V.
AU - Peng X.P.
PY - 2026
DA - 2026/10/31
JO - Current Allergy and Asthma Reports
DO - 10.1007/s11882-026-01303-3
UR - https://doi.org/10.1007/s11882-026-01303-3
AB - Purpose of the review: Genetically driven immune diseases (GIDs) are germline or somatic errors of immunity, representing an expanding and diagnostically complex group of genetic disorders. While genomic advances have enhanced their detection, interpretation of genetic data remains a major challenge due to significant genotypic and phenotypic heterogeneity, incomplete knowledge about genotype–phenotype connections, and the diverse layers of mechanisms contributing to each patient’s specific expression of disease. In this review, we propose a clinically oriented framework for the genetic evaluation of patients with suspected GIDs. Recent findings: Using disorders featuring predominantly adaptive immune dysregulation as representative examples – hypomorphic defects in lymphocyte development (RAG1, RAG2), defects of central tolerance (AIRE), defects of peripheral tolerance (FOXP3), cytokine-mediated immune regulation (IL2RA, IL2RB), activation-induced cell death (FAS), and canonical NF-κB signaling (CARD11 gain-of-function) – we provide a practical approach to the selection and use of clinically available genetic tests, emphasizing context-dependent strategies based on each patient’s clinical and immune findings. We also highlight key limitations of current genetic testing and emerging approaches aimed at improving diagnostic yield. Summary: This review provides a practical, stepwise, mechanism-informed framework for the genetic evaluation of patients with suspected GIDs that integrates clinical phenotyping with immune and genetic data. By emphasizing appropriate test selection, recognition of diagnostic limitations, and the use of complementary approaches in unresolved cases, this framework aims to support accurate molecular diagnosis and personalized management of patients with immune dysregulation.
SN - 1529-7322
SN - 1534-6315
ER -